Other OTC - Delayed Quote USD

RenovaCare, Inc. (RCAR)

0.0001 0.0000 (0.00%)
At close: April 25 at 2:48 PM EDT

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Harmel S. Rayat President, CEO, CFO, Interim Secretary & Chairman of the Board -- -- 1961
Dr. Robin A. Robinson Ph.D. Chairman of Scientific Advisory Board, VP & Chief Scientific Officer 220k -- 1956
Mr. Justin Frere CPA, M.B.A. Treasurer 208.08k -- 1973
Dr. Jo Ellen Schweinle M.D. Chief Medical Officer -- -- --

RenovaCare, Inc.

9375 East Shea Blvd
Suite 107-A
Scottsdale, AZ 85260
United States
888 398 0202 https://www.renovacareinc.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
1

Description

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.

Corporate Governance

RenovaCare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers

PRED Predictive Technology Group, Inc.
0.0005
0.00%
 
ONCT Oncternal Therapeutics, Inc.
8.25
-4.18%
 
SNPX Synaptogenix, Inc.
4.4130
-1.50%
 
IPA ImmunoPrecise Antibodies Ltd.
1.1940
-2.13%
 
SPRC SciSparc Ltd.
1.2600
+4.13%
 
EVGN Evogene Ltd.
0.6587
-1.61%
 
ACST Acasti Pharma Inc.
2.9285
-0.39%
 
ARVN Arvinas, Inc.
31.60
-2.89%
 
VRNA Verona Pharma plc
15.31
+0.46%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.9800
-1.32%